Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases

Mikocka-Walus, Antonina, Knowles, Simon R., Keefer, Laurie and Graff, Lesley 2016, Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases, Inflammatory bowel diseases, vol. 22, no. 3, pp. 752-762, doi: 10.1097/MIB.0000000000000620.

Attached Files
Name Description MIMEType Size Downloads

Title Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases
Author(s) Mikocka-Walus, AntoninaORCID iD for Mikocka-Walus, Antonina
Knowles, Simon R.
Keefer, Laurie
Graff, Lesley
Journal name Inflammatory bowel diseases
Volume number 22
Issue number 3
Start page 752
End page 762
Total pages 11
Publisher Lippincott Williams & Wilkins
Place of publication Philadelphia, Pa.
Publication date 2016-03
ISSN 1078-0998
Keyword(s) anxiety
inflammatory bowel disease
systematic review
Summary BACKGROUND: Although mental health concerns are known to occur commonly for those with inflammatory bowel diseases (IBD), the nature of this comorbid relationship has not been systematically reviewed to date. A review in 2007 identified 5 controversies regarding anxiety/depression rates and various comparators between and within IBD. We aimed to systematically analyze and critique the current evidence regarding this comorbidity, providing an update to the 5 controversies.

METHODS: Ebscohost Medline, CINAHL, Embase, and PsychINFO were searched between 2005 and 2014 using systematic review methodology. Controlled quantitative studies examining either symptoms or diagnoses of anxiety and depression in IBD were included in the review, with study quality assessed using a scale developed a priori to evaluate observational research.

RESULTS: (1) IBD versus healthy controls (pooled mean proportions) (n = 13 studies): anxiety 19.1% versus 9.6%, depression 21.2% versus 13.4%; (2) IBD inactive versus IBD active disease (n = 26): anxiety 28.2% versus 66.4%, depression 19.9% versus 34.7%; (3) ulcerative colitis versus Crohn's disease (n = 28): anxiety 31% versus 37%, depression 22% versus 24.4%; (4) IBD versus other chronic medical conditions (n = 17): anxiety 41.9% versus 48.2%, depression 14.5% versus 28.4%; (5) onset of anxiety/depression before or after IBD onset (n = 2): adults more likely to develop anxiety/depression before IBD onset, but a substantial proportion develops depression after onset; an increased risk for children of developing anxiety/depression after IBD onset.

CONCLUSIONS: The high rates of anxiety and depression for those with IBD, particularly when disease is active, warrant a systemic approach to screening and treatment.
Language eng
DOI 10.1097/MIB.0000000000000620
Field of Research 110399 Clinical Sciences not elsewhere classified
1103 Clinical Sciences
Socio Economic Objective 929999 Health not elsewhere classified
HERDC Research category C1.1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2016, Crohn's & Colitis Foundation of America
Persistent URL

Document type: Journal Article
Collections: Faculty of Health
School of Psychology
Connect to link resolver
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 95 times in TR Web of Science
Scopus Citation Count Cited 96 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 205 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Wed, 09 Nov 2016, 10:31:26 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact